More than 40% of over-80s in England now have Covid antibodies: ONS data shows vaccine roll-out has caused immunity levels among the elderly to rise by more than half in a fortnight
- The number of over-80s testing positive for antibodies in England jumped from 26 to 41 per cent in England
- Office for National Statistics took blood samples from 30,000 adults in England and tested for antibodies
- Found 18.5 per cent tested positive for antibodies, up from 10 per cent in December and 15 per cent in January
- Will be an under-estimate because millions more have been vaccinated since final day of the survey on Feb 1
More than 40 per cent of over-80s in England now have Covid antibodies thanks to the vaccine roll-out, official figures have revealed.
Office for National Statistics data shows the elderly population — who were prioritised for the jab — are rapidly building up immunity against the killer infection.
The number of over-80s testing positive for antibodies in England jumped from 26 to 41 per cent in England in a fortnight, according to the results of the major surveillance study.
But the figure is likely to be even higher now because millions more have been vaccinated since the testing was conducted last month, and it takes about two weeks for the vaccines to kick in. More than nine in 10 over-80s have now had their first dose.
Britain’s coronavirus immunisation drive prioritised the elderly, as well as care homes residents and patients who have other life-threatening illnesses, because they are the most vulnerable to dying from the virus.
Antibodies are immune cells the body makes to fight viruses. They bind to the spike protein on the outside of the coronavirus, preventing it entering cells.
The ONS report published yesterday looked at blood samples taken from 30,000 over-16s across Britain between January 5 and February 1.
One fifth of people in England – approximately 8.3million people – had antibodies against Covid, indicating they had been vaccinated or infected recently. Rates were slightly lower in Scotland, Wales and Northern Ireland.
The ONS found that antibody prevalence was highest in London, where one in four tested positive, and lowest in the South West at just one in nine.
Antibodies are also known to fade over time, which means many people who may have caught the virus during the first wave — and would, therefore, have some form of protection — no longer have measurable levels of the proteins.
The ONS’s survey, which collects regular blood samples from a group of people intended to represent England’s population, showed there was significant variation in antibody positivity between regions.
In London, an estimated one in four had antibodies against the disease by February 1, which was the highest rate across the country, compared to just 11 per cent in the South West.
The North West saw the second highest antibody rate (22 per cent), followed by the West Midlands (21 per cent) and Yorkshire and the Humber (20 per cent). It means four out of nine regions had levels higher than the England average.
While antibodies were most common in over-80s in England, this was not the case in any of the other home nations.
In Wales, for example, the highest percentage of people testing positive was those aged 16 to 24 at 33 per cent, with just 13 per cent of over-80s having antibodies.
Next phase of UK’s Covid vaccine roll-out ‘will focus on ethnicity and NOT occupation’
Ministers will be urged to vaccinate people by age and ethnicity rather than their job during the next phase of the coronavirus jab roll-out, it was claimed today.
Number 10’s leading jab experts, who are due to meet this afternoon to finalise their recommendation, are expected to advise that the UK continues with its age-based approach after the nine most vulnerable groups are inoculated.
The Joint Committee on Vaccination and Immunisation (JCVI) will also urge ministers to prioritise some ethnic minority groups, who are at a disproportionate risk of dying from Covid, The Telegraph reports.
Members are said to be particularly concerned about mortality rates among South Asians, who studies have shown are twice as likely to succumb to the virus as their white peers.
Both Boris Johnson and Matt Hancock have previously said teachers, police officers, shop owners and other key workers could be bumped up the priority list once the top groups have been jabbed.
But JCVI sources said last night prioritising people based on their occupation would ‘create too much complication’ and ‘risk slowing the roll-out down’.
Officials have until now been focusing on vaccinating the top four vulnerable groups — everyone over the age of 70, NHS staff, care home residents and workers, and extremely ill adults.
Yesterday NHS England officially moved onto the second stage of the vaccine drive, inviting over-65s and ‘clinically vulnerable’ younger people. The programme will aim to give everyone over the age of 50 their first dose by the end of April.
NHS England boss Sir Simon Stevens yesterday vowed to double the number of jabs being given in order for the Government to hit that target. It could see up to 1million doses dished out each day.
In Northern Ireland, people aged 25 to 34 were most likely to have the virus-fighting proteins in their blood (22 per cent) and in Scotland it was those aged 16 to 24 years at 15.5 per cent.
The ONS said that small sample sizes in the devolved administrations meant there were bigger confidence intervals – for comparison Wales looked at just 53 over-80s and Scotland tested 107, compared to 1,300 in England.
The survey also only went up to February 1. At that point only 9million people around the UK had been vaccinated, compared to 15.3million as of yesterday.
Because it takes three weeks for antibody levels to build up after a vaccine, an even greater number of people would have been missed by the survey.
Reacting to the findings, Professor Kevin McConway, a statistician at the Open University, said: ‘In previous ONS releases of data from their infection survey about antibodies, we could interpret them as telling us about the numbers of people who had previously been infected by the virus, because for the great majority of people that was really the only way that antibodies could have arisen in their blood.
‘But the antibodies that arise from an infection are the same as the antibodies arising from a vaccination, as far as these data are concerned. The latest ONS release covers the period from 5 January to 1 February this year.
‘Though the numbers of vaccinated people aged 70-74 and 75-79 were increasing rapidly over that period, the average proportion of those age groups that would have been vaccinated was much lower than for people aged 80 and over.’
He added: ‘It must be this vaccination effect that explains the very large proportion on people in England in the 80+ age group that have antibodies to the virus – almost half of them.
‘NHS data for England indicate that about a quarter of the 80+ age group had been vaccinated at the start of the period 5 January-1 February, rising to about 90 per cent by the end of the period.
‘Given that it takes a couple of weeks for the vaccine to take effect, so that antibodies would not be detectable immediately, that fits in with the proportion of this age group that had antibodies according to the ONS survey.
‘Some people in this age group would have antibodies from a previous infection, but most will have got them from vaccination. In next month’s antibody data, we should see the percentages with antibodies in the slightly younger age groups increasing a lot, and the antibody prevalence will continue to move down the age scale as vaccinations are given to more and more younger people.’
It comes after SAGE experts predicted as many as four in 10 people in Britain have already got some level of immunity to Covid-19 from either catching the coronavirus or having a vaccine.
The prediction was made in a paper presented to the Government’s top scientific advisers on January 27.
SPI-M-O, a panel that includes Professor ‘Lockdown’ Neil Ferguson, said in the document: ‘Current estimates are that 20-40 per cent of the population have experienced a primary infection or been vaccinated.’
This suggests that those people have developed some level of protection against developing Covid-19 and this could, in theory, slow down future outbreaks.
They point out, however, that actual immunity may be lower because it can weaken over time. People who were infected a long time ago and didn’t get very ill, for example, may lose their immunity, as may elderly people who don’t make as much of an immune response.
Those who were sick recently or who get very ill, as well as people who have been vaccinated, are likely to be immune at least to severe disease, if not all infection, but scientists still don’t fully understand how often people catch it twice.
Immunity, however, may not protect people against the mutated South African variant of the virus which has been diagnosed more than 200 times in Britain.
A separate study given to SAGE claims this variant, which changes the shape of the virus’s outer spike protein so that immunity to older versions of the virus is less effective, ‘evades 21 per cent of previously acquired immunity’.
This raises concerns about how much life can return to normal after the vaccination programme as measures may need to continue to stop this variant taking over, if it will truly be able to infect a fifth of people who have been vaccinated.
REVEALED: THE TRUTH ON COVID IMMUNITY, ANTIBODIES AND T CELLS
Antibodies are substances produced by the immune system which store memories of how to fight off a specific virus.
They come in different forms and may attack viruses and destroy them themselves, or may force the body to produce other kinds of immune cells and white blood cells to do the dirty work for them.
They can only be created if the body is exposed to the virus by getting infected for real, or through a vaccine or other type of specialist immune therapy.
Once antibodies have been created once – the body essentially moulds them around a virus when it encounters one in the blood – the body usually retains a memory of how to make them and which ones go with which virus.
Generally speaking, antibodies produce immunity to a virus because they are redeployed if it enters the body for a second time, defeating the bug faster than it can take hold and cause an illness.
Scientists are still unsure on the truth on immunity because Covid-19 has only been around since last January – meaning its long-term effects are still unclear.
So far cases of people getting infected more than once have not been numerous nor convincing.
With some illnesses such as chickenpox, the body can remember exactly how to destroy it and becomes able to fend it off before symptoms start if it gets back into the body. But it is so far unclear how long Covid-19 patients are protected for.
Evidence is beginning to suggest that antibodies disappear in as little as eight weeks after infection with the coronavirus, scientifically called SARS-Cov-2. But other studies show they can last for at least six months.
However, antibodies are only one type of substance that can produce immunity. The immune system is a huge web of proteins that have different functions to protect the body against infection.
T cells — which can’t be detected by the ‘have you had it’ antibody tests — made in response to the infection may offer a form of immunity that lasts several times longer.
T cells are a type of white blood cell that are a key component of the immune system and help fight off disease.
Other scientific studies have shown people who have had a common cold in the past two years have T cells that show ‘cross-reactive protection’ against Covid-19.
Source: Read Full Article